PAVMED INC Equity-NMS: PAVM

Healthcare

Medical Devices

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$0.4499

Open :

$0.45

Today's high :

$0.46

Today's low :

$0.43

52W low :

$0.304

52W high :

$1.9

EPS(TTM): :

3.46

Shares O/S :

17.29 M

Market cap :

7.61 M

What is the share price of PAVMED INC today?

PAVMED INC (PAVM) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of PAVMED INC?

Yes, Indian Investors can invest in the PAVMED INC (PAVM) Share by opening an international trading account with Angel One.

How can I purchase PAVMED INC shares in India?

Purchasing PAVMED INC (PAVM) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying PAVMED INC (PAVM) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of PAVMED INC?

Yes, you can purchase fractional shares of PAVMED INC (PAVM) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of PAVMED INC?

The market capitalization of PAVMED INC on January 1, 1970, is $0.

What documents are required to invest in PAVMED INC stocks?

In order to invest in PAVMED INC (PAVM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.